Tarun Goswami obtained his BS in 2003 from Delhi University and his PhD in Pharmaceutical Sciences in 2008 from University of the Pacific (CA, USA). He currently works at Amneal Pharmaceuticals as a formulation Scientist in the Transdermal Drug Delivery Group. He is interested in the development, metabolism and toxicity evaluation of formulations which are administered via alternate route of drug delivery such as skin and oral mucosa. He has developed multiple products in the area of transdermal and sublingual drug delivery. He is also present on the reviewer board and editorial board of many international peer reviewed journals.
Metabolism and toxicology of drug administered from alternative routes of drug delivery.
Specific expertise in drug delivery across skin and oral mucosa.
1. T.Goswami, B.Jasti and X.Li. “Sublingual Drug Delivery”. 2008; Crit. Rev. Ther. Drug Carrier Syst., 25(5):449-484.
2. T. Goswami, B.R. Jasti, X. Li, “Estimation of the Theoretical Pore sizes of the Porcine Oral Mucosa for Permeation of Hydrophilic Permeants”. Arch Oral Biol 54(6) (2009) 577-582.
3. T.Goswami, B.Jasti, A.Kokate and X.Li. “In Silico Model of Drug Permeability across Sublingual Mucosa. Arch Oral Biol (58.5 (2013): 545-551)
4. T.Goswami et al. “Valacyclovir Formulations”, US Patent application number – 20120149720
5. T.Goswami, J Audett “Chemistry, Manufacturing and Controls (CMC) in Passive Transdermal Delivery Systems (TDS)”. Therapeutic Delivery.6(9):1071-1079
6. Lobo, Shabbir, Sameer Sachdeva and Tarun Goswami. "Role of pressure-sensitive adhesives in transdermal drug delivery systems." Therapeutic delivery 7.1 (2016): 33-48.
7. T.Goswami, B.Jasti and X.Li. “Effect of Lipophilicity and Drug Ionization on Permeation across Porcine Sublingual Mucosa”. 2016; AAPS Pharmscitech
8. Lobo, Shabbir, Sameer Sachdeva and Tarun Goswami. "What is the future of noninvasive routes for protein- and peptide-based drugs? ." Therapeutic delivery June 2016.